Hepatitis B Virus: Infection, liver disease, carcinogen or syndemic threat? Remodelling the clinical and public health response

Philippa C Matthews; Tongai Maponga; Indrajit Ghosh; Maud Lemoine; Ponsiano Ocama; Ibrahim Abubakar; Alistair Story; Stuart Flanagan

doi:10.1371/journal.pgph.0001359

Hepatitis B Virus: Infection, liver disease, carcinogen or syndemic threat? Remodelling the clinical and public health response

PLOS Glob Public Health. 2022 Dec 2;2(12):e0001359. doi: 10.1371/journal.pgph.0001359. eCollection 2022.

Authors

Philippa C Matthews^{1

2

3}, Tongai Maponga⁴, Indrajit Ghosh^{5

6}, Maud Lemoine⁷, Ponsiano Ocama⁸, Ibrahim Abubakar⁹, Alistair Story⁶, Stuart Flanagan^{3

5}

Affiliations

¹ The Francis Crick Institute, London, United Kingdom.
² Division of Infection and Immunity, University College London, London, United Kingdom.
³ Department of Infectious Diseases, University College London Hospitals, London, United Kingdom.
⁴ Division of Virology, Tygerberg Hospital, University of Stellenbosch, Stellenbosch, South Africa.
⁵ Mortimer Market Centre, Central North West London NHS Foundation Trust, London, United Kingdom.
⁶ Find & Treat, Inclusion Health, University College London, London, United Kingdom.
⁷ Department of Metabolism, Digestion and Reproduction, Division of Digestive Diseases, Section of Hepatology, Imperial College London, London, United Kingdom.
⁸ Makerere University College of Health Sciences, Kampala, Uganda.
⁹ Faculty of Population Health Sciences, University College London, Mortimer Market Centre, London, United Kingdom.

No abstract available

Grants and funding

PCM is funded by Wellcome, grant reference 110110/Z/15/Z, by the Francis Crick Institute, and by the University College London NIHR Biomedical Research Centre. PO has funding from NIH to study HBV, HIV and liver cancer. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.